United States:
FDA Reclassifies Shortwave Diathermy For All Other Uses
11 November 2015
Jones Day
To print this article, all you need is to be registered or login on Mondaq.com.
In the October 13, 2015, Federal Register, FDA issued
a final order to reclassify shortwave diathermy for all other uses,
a preamendments class III device, into class II (special controls),
and to rename the device ''nonthermal shortwave
therapy.''
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
